Yazdimamaghani joined UNC in 2018. He received his B.S. from Isfahan University of Technology and his M.S. from the University of Tehran. He earned his Ph.D. from the University of Utah in the area of Pharmaceutics and Pharmaceutical Chemistry. He is working under the guidance of Drs. Jon Serody and Chuck Perou. His current work is harnessing the power and specificity of the immune system by cancer immunotherapy to treat lung cancer utilizing neoantigens and nanotechnology.
Mostafa Yazdimamaghani, Ph.D.